Search

2024 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on intermediate filament proteins. According to news originating from the [...]

Researchers at Southwest University in Chongqing, China, have identified high B-sitosterol-D-glucoside (SDG) content in sweet potato varieties as having potential anti-breast cancer properties by inhibiting metastasis. Through proteomic analysis, they found that SDG significantly reduced tumor volume in breast cancer models by affecting proteins associated with epithelial-mesenchymal transition and metastasis. This study highlights SDG as a bioactive compound in sweet potatoes with therapeutic implications for breast cancer treatment. [Extracted from the article]

Researchers at the University of Miami have reported new data on metastatic pleomorphic lobular carcinoma of the breast to the urinary bladder, a rare occurrence with similarities to plasmacytoid urothelial carcinoma. The study aimed to distinguish between the two types of cancer using various markers, including TRPS1. Results showed that MPLC often presents in patients with a history of breast cancer and can be differentiated from PUC based on immunohistochemical markers. The researchers caution that misclassification of these tumors can have significant ramifications. [Extracted from the article]

A recent study conducted by researchers at the University of Bergen has found that the loss of vimentin expression in preoperative biopsies can independently predict poor prognosis, lymph node metastasis, and recurrence in endometrial cancer patients. The study, which included 1483 patients across 14 hospitals in Europe, revealed that vimentin loss was significantly associated with aggressive disease and poor survival outcomes. The researchers suggest that incorporating vimentin as a clinical marker could improve risk stratification and treatment decisions for endometrial cancer patients. [Extracted from the article]

Researchers at Jiangsu Cancer Hospital in the People's Republic of China conducted a study on the effects of Platycodon grandiflorus on doxorubicin resistance and epithelial-mesenchymal transition in breast cancer cells. The study aimed to explore how this plant affects breast cancer cells through the p38 mitogen-activated protein kinase signaling pathway. Results showed that Platycodon grandiflorus could reverse doxorubicin resistance in breast cancer cells and regulate their biological activities by activating the p38 MAPK pathway. This research provides valuable insights into potential treatment options for breast cancer patients. [Extracted from the article]

A recent report from Shanghai Jiao Tong University School of Medicine provides new data on breast cancer. The study focused on the expression of protein arginine methyltransferase 6 (PRMT6) in breast carcinoma tissues and its impact on the behavior of breast cancer cells. The researchers found that PRMT6 is highly expressed in breast cancer tissues and promotes the proliferation and migration of breast cancer cells. This information contributes to our understanding of breast cancer and may have implications for future treatment strategies. [Extracted from the article]

A recent study conducted at Uttar Pradesh University of Medical Sciences in India has found that lymph node metastasis is a significant prognostic marker in breast cancer treatment and is associated with poor prognosis. The study analyzed various variables related to lymph node metastasis, including size, number of lymph nodes involved, and other associated pathologies. The results showed that metastatic lymph node size, number, and other pathologies were correlated with patient age, menopause status, tumor size, grade, invasion, necrosis, calcification, and prognosis. The study concluded that metastatic lymph node can be used as a predictor of poor prognosis and that factors such as age, tumor size, grade, and certain immunohistochemistry markers can also contribute to prognosis. The researchers recommend the use of periodic acid-Schiff (PAS) staining in metastatic lymph nodes for better management of breast cancer patients. [Extracted from the article]

A recent study conducted at the First Affiliated Hospital of Hebei North University in China explored the role of G protein-coupled estrogen receptor (GPER) in cervical cancer. The researchers investigated whether G15, an inhibitor of GPER, could regulate its expression and impact the progression of cervical cancer. The study found that G15 treatment reduced the proliferation, migration, and invasion abilities of cervical cancer cells. Additionally, G15 was found to regulate the GPER/PI3K/AKT/PD-L1 signaling pathway, suggesting its potential as a new immunotherapy for cervical cancer treatment. Further research is needed to explore the implications of these findings. [Extracted from the article]

A recent study conducted at the University of Manchester explored the effects of menopause and hormone replacement therapy (HRT) on the skin barrier and immune system in post-menopausal women. The study found that individuals receiving HRT displayed a stronger skin barrier response to irritant challenge, with thicker filaggrin and increased keratin-10-positive cell layers. Additionally, HRT users exhibited elevated counts of certain immune cells in the dermis, which may make the skin more prone to inflammation but also more capable of resolving it and promoting skin repair. These findings contribute to our understanding of the impact of menopause and HRT on skin health. [Extracted from the article]

A study conducted by researchers at the University-Town Hospital of Chongqing Medical University explores the use of human amniotic mesenchymal stem cells (hAMSCs) in treating intrauterine adhesion (IUA), a leading cause of infertility in women. The study investigates whether the therapeutic effects of stem cells occur through paracrine or transdifferentiation mechanisms. The researchers found that hAMSCs promote endometrial repair primarily through paracrine signaling rather than transdifferentiation. These findings suggest that hAMSCs could be an effective treatment for IUA. [Extracted from the article]

2022 JUN 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New study results on desmin have been published. According to news reporting from the [...]

A study conducted by Fujian Medical University in China explored the role of the transcription factor Dp-1 (TFDP1) in breast cancer (BC) progression. The researchers found that TFDP1, along with anti-silencing function 1B histone chaperone (ASF1B) and CDC28 protein kinase regulatory subunit 1B (CKS1B), were highly expressed in BC cells and positively correlated. Overexpression of TFDP1 and ASF1B enhanced the viability, migration, and invasion of BC cells, while silencing TFDP1, CKS1B, or ASF1B suppressed these behaviors. The study concluded that TFDP1 promotes the malignant behaviors of BC cells by upregulating CKS1B through ASF1B mediation. [Extracted from the article]

The Italian Society for Rheumatology has launched a multicentric study to evaluate the accuracy of non-criteria antiphospholipid antibodies (aPL) in diagnosing Antiphospholipid Syndrome (APS) in patients with thrombosis or recurrent adverse pregnancy outcomes. The study aims to recruit patients who meet the classification criteria for APS, as well as those with seronegative APS or clinical criteria for APS without highly suggestive clinical features. The study will analyze the diagnostic accuracy of non-criteria aPL, compare the clinical characteristics of APS and SN-APS, and examine the association between different aPL status and the recurrence of thrombosis or adverse pregnancy outcomes. The study is expected to be completed by March 31, 2026. [Extracted from the article]

A recent study conducted by researchers at RWTH Aachen University in Germany examined the impact of corpus luteum hormones on the mechanics and receptivity of the human endometrial epithelium. The study found that hormone-induced changes in the mechanical properties of the endometrial epithelium and stroma play a role in supporting embryo adhesion and invasion during the window of implantation. The researchers used hormone-responsive endometrial adenocarcinoma-derived Ishikawa cells to study this process and found that cells on soft substrates were more tightly clustered and uniform compared to cells on stiff substrates. The study also highlighted the role of extracellular matrix and hormones in determining mechanical properties and embryo implantation. [Extracted from the article]

A recent study conducted at the University of Guadalajara in Mexico has examined the role of cancer-associated fibroblasts (CAFs) in the progression of cervical cancer. CAFs are a type of connective tissue cell that play a crucial role in the tumor microenvironment. The study found that CAFs express specific markers, such as fibroblast activation protein (FAP), vimentin, S100A4, and a-smooth muscle actin (aSMA), and functional markers like MMP9. The researchers observed high expression of FAP, vimentin, aSMA, and MMP9 in cervical cancer samples, indicating the importance of these proteins in cervical cancer progression. The findings suggest that FAP may serve as a central activation marker for CAFs in cervical cancer. [Extracted from the article]

A study conducted by researchers at Capital Medical University in Beijing, China, aimed to understand the mechanism of metformin in treating ovarian cancer (OC). The study found that metformin inhibited the proliferation, migration, and invasion of OC cells, while inducing apoptosis. It also reduced the expression of Cyclin B1 (CCNB1) and inhibited the PI3K/mTOR signaling pathway and epithelial-mesenchymal transition (EMT). These findings suggest that metformin may be a potential treatment for OC by targeting these pathways. The study was funded by the Natural Science Foundation of Shanxi Province and the Shanxi Province Key National Science and Technology Cooperation Projects. [Extracted from the article]

A recent preprint abstract discusses the spatial relationships between different cell populations within the tumor microenvironment (TME) of breast cancer. The study used imaging mass cytometry to analyze protein expression in tumor samples, focusing on metastasis-initiating cell populations. The researchers found that these aggressive cancer cells were in close proximity to specific fibroblast and macrophage subtypes, and this relationship was consistent between primary and metastatic tumors. The study suggests that these cell-cell interactions may play a role in promoting metastasis. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

A recent report discusses new research on endometriosis conducted by investigators at Capital Medical University in Beijing, China. The study focuses on the role of endometrial stromal cells (ESCs) in the development of endometriosis, an estrogen-dependent disease characterized by the growth of endometrial tissue outside the uterus. The researchers found that metformin, a medication commonly used to treat diabetes, inhibited the proliferation, migration, and invasion of ectopic ESCs in a dose-dependent manner. Additionally, metformin downregulated the expression of certain markers associated with epithelial-mesenchymal transition (EMT) and reduced the expression and nuclear translocation of ß-catenin in EESCs. These findings suggest that metformin may have therapeutic potential for endometriosis. [Extracted from the article]

Dana-Farber Cancer Institute Inc. has been issued a patent for compositions and methods for treating peroxisome proliferator-activated receptor gamma (PPARG) activated cancers, such as breast cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular cancer, and bladder cancer. The patent describes the use of PPARG signaling modulators, including inverse-agonists, to down-regulate PPARG signaling and decrease cellular proliferation associated with these cancers. The patent also mentions the potential use of molecular genetic methodologies, such as CRISPR/Cas and RNAi, to edit gene sequences and mutations that cause PPARG activated cancers. The patent claims include methods of treating subjects with PPARG activated cancer by administering a therapeutically effective amount of a PPARG signaling modulator. [Extracted from the article]

A study conducted at Hangzhou Red Cross Hospital in Zhejiang, China, investigated the inhibitory effect of hirudin on the cell proliferation of human ovarian cancer cells. The researchers found that hirudin, a blood coagulation factor, effectively inhibited the promotion of cell proliferation by thrombin. It was also found to downregulate the expression of genes associated with epithelial-mesenchymal transition (EMT), which is relevant to cancer progression. These findings suggest that hirudin may have therapeutic potential as an anti-cancer agent for ovarian cancer. The research was supported by the Traditional Chinese Medicine Science and Technology Program Project of Zhejiang Province. [Extracted from the article]

A patent application titled "Virtual Staining For Tissue Slide Images" has been published online by the US Patent and Trademark Office. The application, filed by inventors Philip Nelson, Lily Peng, and Martin Stumpe, and assigned to Verily Life Sciences LLC, describes a method for generating artificial or virtual images of tissue specimens stained with special stains. These virtual images can be created from unstained images or images stained with a different stain, such as hematoxylin and eosin (H&E). The method aims to reduce costs and time associated with obtaining actual stained images, provide previews for pathologists, and supplement other predictions related to tissue samples. The patent application provides details on the system, methods, and computer programs used for generating these virtual stained images. [Extracted from the article]

A recent study conducted by researchers from the University of Airlangga in East Java, Indonesia, explored the mechanisms of early local recurrence in different types of breast cancer. The study found that the tumor microenvironment and immune system play a role in recurrence, with different mechanisms observed in ductal and lobular types of breast cancer. The researchers suggest that enhancing the immune system may be a potential treatment option for breast cancer. This study provides valuable insights into the understanding and management of early-stage breast cancer. [Extracted from the article]

A recent study conducted by researchers at the University of Southern California (USC) has found that a truncated isoform of keratin 81 (tKRT81) is upregulated in metastatic breast cancer lesions compared to primary tumors and circulating tumor cells. This upregulation is associated with more aggressive subtypes of breast cancer. The study also revealed that tKRT81 physically interacts with keratin 18 (KRT18), leading to changes in the cytosolic keratin intermediate filament network and desmosomal plaque formation. These structural changes result in softer and more deformable cancer cells with enhanced adhesion and clustering abilities, ultimately promoting greater lung metastasis. This research highlights the importance of the biophysical characteristics of tumor cells in understanding breast cancer metastasis. [Extracted from the article]

A recent study conducted at Daqing Oilfield General Hospital explored the role of a specific gene, HOTAIR, in cervical cancer cells. The researchers used small interfering RNA to silence the HOTAIR gene in two human cervical cancer cell lines and observed the effects on cell proliferation, apoptosis, migration, and invasion. They found that HOTAIR knockdown significantly reduced cell viability, migration ability, and induced cell apoptosis. The study suggests that targeting HOTAIR with specific siRNA could be a potential therapeutic avenue for cervical cancer treatment. This research contributes to the development of new treatment options and identifies new targets for further investigation. [Extracted from the article]

A scoping review conducted by researchers at the University of Wisconsin School of Medicine and Public Health explores the prognostic and predictive significance of cytokeratin 17 (K17) in human cancers. The review analyzed 58 studies that evaluated the association between K17 and clinical outcomes in various cancer types. The findings suggest that K17 is a negative prognostic factor in the majority of cancer types studied, including HPV-associated types such as head and neck squamous cell carcinoma (HNSCC) and cervical cancer. However, K17 was found to be a positive prognostic factor in urothelial carcinoma of the upper urinary tract and breast cancer. Additionally, K17 was identified as a negative predictive factor for chemotherapy and immune checkpoint blockade therapy response in some cases. [Extracted from the article]

A recent study conducted at the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital in Beijing, China, explored the potential therapeutic role of Icariside I (ICS I) in Epimedium flavonoids (EF) for breast cancer prevention. The researchers found that EF can inhibit the phosphorylation of STAT3 and reduce the colony formation and migration of breast cancer cells. Additionally, ICS I was found to induce G1 phase arrest in breast cancer cells and suppress tumor development and lung metastasis in a mouse model. These findings suggest that ICS I has the potential to be a promising candidate for breast cancer prevention and treatment. [Extracted from the article]

A recent report from Soochow University in Jiangsu, China discusses new findings on the inhibitory effects of telocyte-induced M1 macrophages on endometriosis. Telocytes are a type of stromal cells found in tissues that can enhance the phagocytic function of macrophages. The study found that telocyte-induced M1 macrophages can inhibit the expression of angiogenic and invasive factors in endometrial stromal cells, potentially through the suppression of the NF-Kb pathway. This research provides a promising therapeutic approach for endometriosis by targeting angiogenesis and invasion. [Extracted from the article]

Additionally, often there is insufficient tissue available for all the stain images a pathologist may want to obtain to make a diagnosis, with normally each stain image requiring a separate slice of the tissue from a block of tissue. The input image could be an unstained image of the tissue specimen, or alternatively an image of the tissue specimen stained with a first stain, typically hematoxylin and eosin (H&E). "Images of tissue specimens stained with special stains are relatively expensive to obtain due to the cost of the stains themselves (some of which are five times more expensive than an H&E stain), and labor and equipment costs. [Extracted from the article]

Zagazig, Egypt, Africa, Bioengineering, Biomarkers, Biomedical Engineering, Biomedicine, Biotechnology, Caspase, Diagnostics and Screening, Drugs and Therapies, Endometriosis, Enzymes and Coenzymes, Female Genital Diseases and Conditions, Female Urogenital Diseases and Conditions, Health and Medicine, Intermediate Filament Proteins, Tissue Engineering, Uterine Diseases and Conditions, Vimentin, Women's Health Keywords: Zagazig; Egypt; Africa; Bioengineering; Biomarkers; Biomedical Engineering; Biomedicine; Biotechnology; Caspase; Diagnostics and Screening; Drugs and Therapies; Endometriosis; Enzymes and Coenzymes; Female Genital Diseases and Conditions; Female Urogenital Diseases and Conditions; Health and Medicine; Intermediate Filament Proteins; Tissue Engineering; Uterine Diseases and Conditions; Vimentin; Women's Health EN Zagazig Egypt Africa Bioengineering Biomarkers Biomedical Engineering Biomedicine Biotechnology Caspase Diagnostics and Screening Drugs and Therapies Endometriosis Enzymes and Coenzymes Female Genital Diseases and Conditions Female Urogenital Diseases and Conditions Health and Medicine Intermediate Filament Proteins Tissue Engineering Uterine Diseases and Conditions Vimentin Women's Health 375 375 1 10/30/23 20231103 NES 231103 2023 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on Biomedical Engineering - Tissue Engineering is the subject of a report. [Extracted from the article]

Keywords: Zhejiang; People's Republic of China; Asia; Cadherins; Cell Adhesion Molecules; Cell Research; Collagen; Endometriosis; Extracellular Matrix Proteins; Female Genital Diseases and Conditions; Glycoproteins; Gynecology; Health and Medicine; Intermediate Filament Proteins; Membrane Proteins; Uterine Diseases and Conditions; Vimentin; Women's Health EN Zhejiang People's Republic of China Asia Cadherins Cell Adhesion Molecules Cell Research Collagen Endometriosis Extracellular Matrix Proteins Female Genital Diseases and Conditions Glycoproteins Gynecology Health and Medicine Intermediate Filament Proteins Membrane Proteins Uterine Diseases and Conditions Vimentin Women's Health 351 351 1 10/30/23 20231103 NES 231103 2023 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on Uterine Diseases and Conditions - Endometriosis have been presented. Keywords for this news article include: Zhejiang, People's Republic of China, Asia, Cadherins, Cell Adhesion Molecules, Cell Research, Collagen, Endometriosis, Extracellular Matrix Proteins, Female Genital Diseases and Conditions, Glycoproteins, Gynecology, Health and Medicine, Intermediate Filament Proteins, Membrane Proteins, Uterine Diseases and Conditions, Vimentin, Women's Health, Zhejiang University. [Extracted from the article]

Breast Cancer, Cancer, Health and Medicine, Intermediate Filament Proteins, Oncology, Vimentin, Women's Health According to news originating from Lisbon, Portugal, by NewsRx correspondents, research stated, "Among breast cancer (BC) subtypes, the most aggressive is triple negative BC (TNBC), which is prone to metastasis." Keywords: Breast Cancer; Cancer; Health and Medicine; Intermediate Filament Proteins; Oncology; Vimentin; Women's Health EN Breast Cancer Cancer Health and Medicine Intermediate Filament Proteins Oncology Vimentin Women's Health 1378 1378 1 10/09/23 20231013 NES 231013 2023 OCT 10 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in breast cancer. [Extracted from the article]

Thus, targeting CANP10 or NRP1 may be a novel strategy for preventing tamoxifen-induced endometrial cancer metastasis." Keywords: Shandong; People's Republic of China; Asia; Benzene Derivatives; Cadherins; Cancer; Cell Adhesion Molecules; Cell Research; Endometrial Cancer; Glycoproteins; Gynecology; Health and Medicine; Intermediate Filament Proteins; Membrane Proteins; Oncology; Stilbenes; Tamoxifen; Vimentin; Women's Health EN Shandong People's Republic of China Asia Benzene Derivatives Cadherins Cancer Cell Adhesion Molecules Cell Research Endometrial Cancer Glycoproteins Gynecology Health and Medicine Intermediate Filament Proteins Membrane Proteins Oncology Stilbenes Tamoxifen Vimentin Women's Health 894 894 1 10/09/23 20231013 NES 231013 2023 OCT 10 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Research findings on Oncology - Endometrial Cancer are discussed in a new report. [Extracted from the article]

Keywords: Apoptosis Regulatory Proteins; Brain Diseases and Conditions; Brain Research; Caspase; Caspases; Central Nervous System; Central Nervous System Diseases and Conditions; Cerebral Cortex; Cysteine Endopeptidases; Cysteine Proteases; Cytoskeletal Proteins; Dermatology; Drug Resistance; Drugs and Therapies; Dysplasia; Effector Caspases; Enzymes and Coenzymes; Epilepsy; Gender Health; Gender and Health; Health and Medicine; Intermediate Filament Proteins; Peptide Hydrolases; Peptides; Peptides and Proteins; Prosencephalon; Proteins; Telencephalon; Temporal Lobe; Temporal Lobe Epilepsy; Vimentin; Women's Health EN Apoptosis Regulatory Proteins Brain Diseases and Conditions Brain Research Caspase Caspases Central Nervous System Central Nervous System Diseases and Conditions Cerebral Cortex Cysteine Endopeptidases Cysteine Proteases Cytoskeletal Proteins Dermatology Drug Resistance Drugs and Therapies Dysplasia Effector Caspases Enzymes and Coenzymes Epilepsy Gender Health Gender and Health Health and Medicine Intermediate Filament Proteins Peptide Hydrolases Peptides Peptides and Proteins Prosencephalon Proteins Telencephalon Temporal Lobe Temporal Lobe Epilepsy Vimentin Women's Health 2525 2525 1 10/09/23 20231013 NES 231013 2023 OCT 13 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A new study on temporal lobe epilepsy is now available. [Extracted from the article]

Compared with the clear tumor border group, the unclear tumor border group was associated with higher incidence rates of recurrence (3/40 vs. 3/13, respectively), lymphovascular space invasion (24/40 vs. 13/13, respectively), lymph node metastasis (6/40 vs. 10/13, respectively), and positivity for vimentin (18/40 vs. 10/13, respectively)." According to MRI findings, an unclear tumor border in patients with squamous cell cervical cancer is linked to poorer prognosis, lymph node metastasis, and distant recurrence of metastasis." Keywords: Cancer; Cervical Cancer; Health and Medicine; Hemic and Immune Systems; Immunology; Intermediate Filament Proteins; Lymph Nodes; Lymphoid Tissue; Magnetic Resonance; Oncology; Vimentin; Women's Health EN Cancer Cervical Cancer Health and Medicine Hemic and Immune Systems Immunology Intermediate Filament Proteins Lymph Nodes Lymphoid Tissue Magnetic Resonance Oncology Vimentin Women's Health 875 875 1 10/03/23 20231006 NES 231006 2023 OCT 3 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New study results on cervical cancer have been published. [Extracted from the article]

Keywords for this news article include: Medical School, Nuremberg, Germany, Europe, Oncology, Vimentin, Cadherins, Gynecology, Cell Research, Glycoproteins, Ovarian Cancer, Women's Health, Membrane Proteins, Health and Medicine, Cell Adhesion Molecules, Intermediate Filament Proteins. Keywords: Cadherins; Cancer; Cell Adhesion Molecules; Cell Research; Glycoproteins; Gynecology; Health and Medicine; Intermediate Filament Proteins; Membrane Proteins; Oncology; Ovarian Cancer; Vimentin; Women's Health EN Cadherins Cancer Cell Adhesion Molecules Cell Research Glycoproteins Gynecology Health and Medicine Intermediate Filament Proteins Membrane Proteins Oncology Ovarian Cancer Vimentin Women's Health 598 598 1 10/03/23 20231006 NES 231006 2023 OCT 3 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on ovarian cancer. [Extracted from the article]

Heilongjiang, People's Republic of China, Asia, Breast Cancer, Cadherins, Cancer, Cell Adhesion Molecules, Cell Line, Cell Research, Glycoproteins, Health and Medicine, Intermediate Filament Proteins, Membrane Proteins, Oncology, Vimentin, Women's Health Keywords: Heilongjiang; People's Republic of China; Asia; Breast Cancer; Cadherins; Cancer; Cell Adhesion Molecules; Cell Line; Cell Research; Glycoproteins; Health and Medicine; Intermediate Filament Proteins; Membrane Proteins; Oncology; Vimentin; Women's Health EN Heilongjiang People's Republic of China Asia Breast Cancer Cadherins Cancer Cell Adhesion Molecules Cell Line Cell Research Glycoproteins Health and Medicine Intermediate Filament Proteins Membrane Proteins Oncology Vimentin Women's Health 1025 1025 1 09/19/23 20230922 NES 230922 2023 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on Oncology - Breast Cancer have been presented. [Extracted from the article]

Paclitaxel (PTX) is a crucial component of CC chemotherapy, but drug resistance to PTX is a major challenge." Keywords: Zhejiang; People's Republic of China; Asia; Antineoplastics; Apoptosis; Apoptosis Regulatory Proteins; Cancer; Caspase; Caspases; Cellular Physiology; Cervical Cancer; Cycloparaffins; Cysteine Endopeptidases; Cysteine Proteases; Diterpenes; Drugs and Therapies; Effector Caspases; Enzymes and Coenzymes; Health and Medicine; Hydrocarbons; Intermediate Filament Proteins; Mitotic Inhibitors; Oncology; Organic Chemicals; Paclitaxel Therapy; Peptide Hydrolases; Peptides; Pharmaceuticals; Taxoids; Terpenes; Vimentin; Women's Health EN Zhejiang People's Republic of China Asia Antineoplastics Apoptosis Apoptosis Regulatory Proteins Cancer Caspase Caspases Cellular Physiology Cervical Cancer Cycloparaffins Cysteine Endopeptidases Cysteine Proteases Diterpenes Drugs and Therapies Effector Caspases Enzymes and Coenzymes Health and Medicine Hydrocarbons Intermediate Filament Proteins Mitotic Inhibitors Oncology Organic Chemicals Paclitaxel Therapy Peptide Hydrolases Peptides Pharmaceuticals Taxoids Terpenes Vimentin Women's Health 489 489 1 09/19/23 20230922 NES 230922 2023 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Current study results on Oncology - Cervical Cancer have been published. [Extracted from the article]

Breast Cancer, Cancer, Health and Medicine, Intermediate Filament Proteins, Oncology, Vimentin, Women's Health Keywords: Breast Cancer; Cancer; Health and Medicine; Intermediate Filament Proteins; Oncology; Vimentin; Women's Health EN Breast Cancer Cancer Health and Medicine Intermediate Filament Proteins Oncology Vimentin Women's Health 1599 1599 1 09/11/23 20230912 NES 230912 2023 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on breast cancer have been presented. [Extracted from the article]

Keywords: Biopolymers; Breast Cancer; Cancer; Cell Proliferation; Cytoplasm; Cytoskeletal Proteins; Genetics; Health and Medicine; Intermediate Filament Proteins; Intracellular Space; Keratin-19; Keratins; Oncology; Proteins; Scleroproteins; Type I Keratins; Women's Health EN Biopolymers Breast Cancer Cancer Cell Proliferation Cytoplasm Cytoskeletal Proteins Genetics Health and Medicine Intermediate Filament Proteins Intracellular Space Keratin-19 Keratins Oncology Proteins Scleroproteins Type I Keratins Women's Health 1013 1013 1 09/04/23 20230905 NES 230905 2023 SEP 5 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Current study results on breast cancer have been published. Biopolymers, Breast Cancer, Cancer, Cell Proliferation, Cytoplasm, Cytoskeletal Proteins, Genetics, Health and Medicine, Intermediate Filament Proteins, Intracellular Space, Keratin-19, Keratins, Oncology, Proteins, Scleroproteins, Type I Keratins, Women's Health. [Extracted from the article]

Keywords: Jalisco; Mexico; North and Central America; Cancer; DNA-Binding Proteins; Health and Medicine; Intercellular Signaling Peptides and Proteins; Intermediate Filament Proteins; Membrane Proteins; NF-kappa B; Nuclear Proteins; Oncology; Proteins; Transcription Factors; Transforming Growth Factors; Tumor Necrosis Factors; Vimentin EN Jalisco Mexico North and Central America Cancer DNA-Binding Proteins Health and Medicine Intercellular Signaling Peptides and Proteins Intermediate Filament Proteins Membrane Proteins NF-kappa B Nuclear Proteins Oncology Proteins Transcription Factors Transforming Growth Factors Tumor Necrosis Factors Vimentin 1315 1315 1 09/04/23 20230905 NES 230905 2023 SEP 5 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Fresh data on Cancer are presented in a new report. PenToXifylline (PTX) possesses potent anti-inflammatory effects by inhibiting NF-kappa B activity. [Extracted from the article]

For more information on this research see: Co-expression of galectin-3 and vimentin in triple negative breast cancer cells promotes tumor progression, metastasis and survival. Keywords: Antiparasitics; Breast Cancer; Cancer; Drug Resistance; Drugs and Therapies; Galectin 3; Galectins; Health and Medicine; Intermediate Filament Proteins; Lectins; Oncology; Proteins; Vimentin; Women's Health EN Antiparasitics Breast Cancer Cancer Drug Resistance Drugs and Therapies Galectin 3 Galectins Health and Medicine Intermediate Filament Proteins Lectins Oncology Proteins Vimentin Women's Health 694 694 1 08/28/23 20230829 NES 230829 2023 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in breast cancer. [Extracted from the article]

Keywords: Cancer; Health and Medicine; Intercellular Signaling Peptides and Proteins; Intermediate Filament Proteins; Membrane Proteins; Oncology; Transforming Growth Factors; Tumor Necrosis Factors; Vimentin EN Cancer Health and Medicine Intercellular Signaling Peptides and Proteins Intermediate Filament Proteins Membrane Proteins Oncology Transforming Growth Factors Tumor Necrosis Factors Vimentin 1046 1046 1 07/31/23 20230801 NES 230801 2023 AUG 1 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on cancer have been presented. Cancer, Health and Medicine, Intercellular Signaling Peptides and Proteins, Intermediate Filament Proteins, Membrane Proteins, Oncology, Transforming Growth Factors, Tumor Necrosis Factors, Vimentin. [Extracted from the article]

Primary objective of this study was to describe the expression of IHC markers-estrogen receptor (ER), vimentin, monoclonal carcinoembryonic antigen (CEA), P16 in EMA and ECA." Adenocarcinoma, Biomarkers, Cancer, Diagnostics and Screening, Gynecology, Health and Medicine, Intermediate Filament Proteins, Oncology, Vimentin, Women's Health Keywords: Adenocarcinoma; Biomarkers; Cancer; Diagnostics and Screening; Gynecology; Health and Medicine; Intermediate Filament Proteins; Oncology; Vimentin; Women's Health EN Adenocarcinoma Biomarkers Cancer Diagnostics and Screening Gynecology Health and Medicine Intermediate Filament Proteins Oncology Vimentin Women's Health 1003 1003 1 07/17/23 20230717 NES 230717 2023 JUL 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Fresh data on adenocarcinoma are presented in a new report. [Extracted from the article]

Keywords: Antibiotics; Antineoplastics; Breast Cancer; Cancer; Diet and Nutrition; Doxorubicin Therapy; Drugs and Therapies; Health and Medicine; Intermediate Filament Proteins; Oncology; Pharmaceuticals; Vimentin; Vitamin D; Vitamins; Women's Health EN Antibiotics Antineoplastics Breast Cancer Cancer Diet and Nutrition Doxorubicin Therapy Drugs and Therapies Health and Medicine Intermediate Filament Proteins Oncology Pharmaceuticals Vimentin Vitamin D Vitamins Women's Health 573 573 1 07/10/23 20230711 NES 230711 2023 JUL 11 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New study results on breast cancer have been published. For more information on this research see: The Effect of the Synergistic Combination of Vitamin D and Doxorubicin on the MCF-7 Line Breast Cancer Cells. [Extracted from the article]

The significance of classifier genes was validated by quantitative Real-Time PCR, cell transfection, cell colony formation assay, wound healing assay, cell proliferation assay, and Western blot. Keywords: Cancer; Cell Proliferation; Cervical Cancer; Health and Medicine; Intermediate Filament Proteins; Oncology; Vimentin; Women's Health EN Cancer Cell Proliferation Cervical Cancer Health and Medicine Intermediate Filament Proteins Oncology Vimentin Women's Health 138 138 1 06/26/23 20230627 NES 230627 2023 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New study results on cervical cancer have been published. [Extracted from the article]

Furthermore, CA directly interacted with Wnt/beta-catenin signaling coreceptor LRP6 and reduced LRP6, p-LRP6, and beta-catenin expression levels in MCF-7 cells. Keywords: Nanning; People's Republic of China; Asia; Breast Cancer; Cadherins; Cancer; Carbocyclic Acids; Cell Adhesion Molecules; Cell Research; Chlorogenic Acid; Cinnamates; Cyclohexanecarboxylic Acids; Glycoproteins; Health and Medicine; Intermediate Filament Proteins; Membrane Proteins; Oncology; Vimentin; Women's Health EN Nanning People's Republic of China Asia Breast Cancer Cadherins Cancer Carbocyclic Acids Cell Adhesion Molecules Cell Research Chlorogenic Acid Cinnamates Cyclohexanecarboxylic Acids Glycoproteins Health and Medicine Intermediate Filament Proteins Membrane Proteins Oncology Vimentin Women's Health 483 483 1 06/26/23 20230627 NES 230627 2023 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Current study results on Oncology - Breast Cancer have been published. [Extracted from the article]

Breast Cancer, Cancer, Health and Medicine, Intermediate Filament Proteins, Oncology, Vimentin, Women's Health Keywords: Breast Cancer; Cancer; Health and Medicine; Intermediate Filament Proteins; Oncology; Vimentin; Women's Health EN Breast Cancer Cancer Health and Medicine Intermediate Filament Proteins Oncology Vimentin Women's Health 95 95 1 05/22/23 20230526 NES 230526 2023 MAY 23 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on breast cancer is the subject of a new report. [Extracted from the article]